GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rhythm Pharmaceuticals Inc (STU:1RV) » Definitions » Additional Paid-In Capital

Rhythm Pharmaceuticals (STU:1RV) Additional Paid-In Capital : €1,009.99 Mil(As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Rhythm Pharmaceuticals Additional Paid-In Capital?


Rhythm Pharmaceuticals's quarterly additional paid-in capital declined from Sep. 2023 (€984.44 Mil) to Dec. 2023 (€975.97 Mil) but then increased from Dec. 2023 (€975.97 Mil) to Mar. 2024 (€1,009.99 Mil).

Rhythm Pharmaceuticals's annual additional paid-in capital increased from Dec. 2021 (€719.54 Mil) to Dec. 2022 (€919.79 Mil) and increased from Dec. 2022 (€919.79 Mil) to Dec. 2023 (€975.97 Mil).


Rhythm Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for Rhythm Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhythm Pharmaceuticals Additional Paid-In Capital Chart

Rhythm Pharmaceuticals Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only 545.68 514.38 719.54 919.79 975.97

Rhythm Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 917.14 914.86 984.44 975.97 1,009.99

Rhythm Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Rhythm Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Rhythm Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhythm Pharmaceuticals (STU:1RV) Business Description

Traded in Other Exchanges
Address
222 Berkeley Street, 12th Floor, Boston, MA, USA, 02116
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.

Rhythm Pharmaceuticals (STU:1RV) Headlines

No Headlines